oalib

Publish in OALib Journal

ISSN: 2333-9721

APC: Only $99

Submit

Search Results: 1 - 10 of 2348 matches for " Tomasz Lazowski "
All listed articles are free for downloading (OA Articles)
Page 1 /2348
Display every page Item
Fatal Urosepsis: A 41 Year-Old Pregnant Woman—Case Report  [PDF]
Malgorzata Gosciniak, Dariusz Kawecki, Malgorzata Miklaszewska, Zenon Truszewski, Tomasz Lazowski, Miroslaw Wielgos, Piotr Radziszewski
Open Journal of Urology (OJU) , 2014, DOI: 10.4236/oju.2014.411024
Abstract: Introduction: Urinary tract infections are one of the most frequent infectious complications during pregnancy [1], while acute pyelonephritis is the main non-obstetric reason for hospitalisation [2] [3]and septic shock in pregnant women. Objectives and methods: The aim of our study is to analyse the diagnostics and treatment of a 41-year-old pregnant woman with the most severe form of urinary tract infection—urosepsis. Case report: A 41-year old woman in the 12th week of pregnancy hospitalised at Intensive Care Unit (ICU) after urological intervention (JJ stent). On the first day after the intervention, the patient was diagnosed as having urosepsis. Scores: SOFA 14 pts, APACHE II 26 pts, SAPS II SCORE 61 pts. Second day in ICU: spontaneous abortion. Microbiological investigation: Escherichia coli—extended-spectrum beta-lactamase (ESBL+). Conclusions: Apregnant patient with a complicated infection of the urinary system ought to be treated in a multi-profile hospital, offering a possibility to consult doctors of various specialisations (urologist, gynaecologist, anaesthesiologist, nephrologist) as well as full access to a radiology laboratory, which will ensure the choice of appropriate and safe treatment for both the mother and the developing foetus.
10th Annual Meeting of Polish oncology pharmacists
Jerzy Lazowski
European Journal of Oncology Pharmacy , 2010,
Abstract: This meeting highlighted both the necessity and opportunities for oncology pharmacy in Poland as in other European countries.
7th annual meeting of Polish oncology pharmacists
Jerzy Lazowski
European Journal of Oncology Pharmacy , 2007,
Abstract: Lectures by prominent oncologists, sponsored workshops and a philosophical reflection on quality of life contributed to a fascinating meeting of Polish oncology pharmacists.
Targeted treatment: hyperthermia, markers for individual variation and barcodes
Jerzy Lazowski
European Journal of Oncology Pharmacy , 2007,
Abstract: For 15 years pharmacists have been meeting together to exchange ideas about oncology in the NZW workshop Onkologisch Pharmazeutischer Fachkongress held annually at the end of January in Hamburg. The meeting has grown from 90 participants in 1993 to now more than 700.
Polish-German conference on oncology pharmacy
Jerzy Lazowski
European Journal of Oncology Pharmacy , 2010,
Abstract: Polish-German conferences in oncology pharmacy have become an established tradition. The 6th conference took place in Dresden, Germany, on 12–13 June 2009, with the theme ‘Training close to practice with certainty’.
Dasatinib in the treatment of chronic myeloid leukaemia
Jerzy Lazowski
European Journal of Oncology Pharmacy , 2008,
Abstract: Dasatinib is one of a new generation of tyrosine kinase inhibitors. It has great potential to retain its activity where imatinib meets resistance and is generally well tolerated. Now is the time to get a better idea of its place in clinical use.
8th Annual meeting of Polish oncology pharmacists
Jerzy Lazowski
European Journal of Oncology Pharmacy , 2008,
Abstract: Death is the natural end of life rather than the failure of treatment. The Polish annual meeting considered philosophical questions of death and palliative care.
National News
Eva Honoré,Jerzy Lazowski
European Journal of Oncology Pharmacy , 2008,
Abstract:
Noninvasive high frequency jet ventilation for patients with cardiogenic pulmonary oedema
T Lazowski, G Opolski, P Andruszkiewicz
Critical Care , 2004, DOI: 10.1186/cc2478
Abstract: In our preliminary study we studied eight patients with ARF due to CPO ventilated noninvasivelly with high frequency jet ventilation (HFJV). A Paravent PAT E jet ventilator was used (FiO2 = 0.6, f = 2 Hz). PaO2, PaCO2, pH, saturation were measured and dyspnoea was estimated before and every 30 min of ventilation.PaO2 values before and during HFJV are shown in Fig. 1. Mean ventilation time was 4 hours. In 1/8 patients HFJV was ineffective; the patient (no. 8) was intubated and ventilated conventionally.In patients with ARF due to CPO noninvasive HFJV is: (1) effective in reversing life-threatening hypoxemia and respiratory acidosis; (2) well tolerated by patients.
National News
Jerzy Lazowski,Samo Ro?man,Monika Sonc
European Journal of Oncology Pharmacy , 2007,
Abstract:
Page 1 /2348
Display every page Item


Home
Copyright © 2008-2017 Open Access Library. All rights reserved.